Children’s FLONASE® Allergy Relief—OTC allergy relief in

the children’s allergy

section of the store

 

Children’s FLONASE® Allergy Relief—OTC allergy relief in the children’s allergy section of the store

Available for children ages 4+

  • Full prescription-strength
  • Works to block 6 key inflammatory mediators—not just histamine*1-4
  • Treats itchy, watery eyes5-9

Onset of Action

For some patients, 24-hour relief begins with the first dose10-12

  • In some patients, Children’s FLONASE® Allergy Relief starts to act in 2 to 4 hours10-12
  • Most patients will have achieved some relief in 12 hours10-12
  • Notable symptom improvement in 24 hours10-12
  • Maximum benefit achieved in 3 to 4 days10-12

For maximum benefit, advise patients to continue taking Children’s FLONASE® Allergy Relief for several days, then make it part of their daily routine as long as they are exposed to allergens.9,13,14

*Mechanism vs most allergy pills. Children’s FLONASE® acts on multiple inflammatory mediators (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.

Children’s FLONASE® Allergy Relief Drug Facts9

Active ingredient: Fluticasone propionate

Uses: Temporarily relieves nasal congestion, runny nose, sneezing, itchy nose, and itchy, watery eyes9

VIEW FULL DRUG FACTS

Children’s FLONASE® Allergy Relief Clinical Profile

Learn more about the Children’s FLONASE® Allergy Relief clinical profile, including efficacy, patient preference, safety and more.

VIEW THE CLINICAL PROFILE

RESOURCES

Patient education materials and more

PATIENT TYPES

Explore different patient types and find out which product is right for your patients

DOSING

Learn more about Children’s FLONASE® Allergy Relief Administration and Dosing

References

1. Derendorf, H. and Meltzer, E. O. Molecular and Clinical Pharmacology of Intranasal Corticosteroids: Clinical and Therapeutic Implications. Allergy: European Journal of Allergy and Clinical Immunology. 63(10): 1292-1300, 2008. 2. Gelfand, E. W. Inflammatory Mediators in Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 114(5 SUPPL.): S135-S138, 2004. 3. White, M. V. and Kaliner, M. A. Mediators of Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 90(4 II): 699-704, 1992. 4. Bachert, C. and Geveart, P. Effect of Intranasal Corticosteroids on Release of Cytokines and Inflammatory Mediators. Allergy: European Journal of Allergy and Clinical Immunology, Supplement. 54(57): 116-123, 1999. 5. Haye, R. and Gomez, E. G. A Multicentre Study to Assess Long-Term Use of Fluticasone Propionate Aqueous Nasal Spray in Comparison With Beclomethasone Dipropionate Aqueous Nasal Spray in the Treatment of Perennial Rhinitis. Rhinology. 31(4): 169-174, 1993. 6. Bernstein, D. I., Levy, A. L., Hampel, F. C., Baidoo, C. A. et al. Treatment With Intranasal Fluticasone Propionate Significantly Improves Ocular Symptoms in Patients With Seasonal Allergic Rhinitis. Clinical and Experimental Allergy. 34(6): 952-957, 2004. 7. DeWester, J., Philpot, E. E., Westlund, R. E., Cook, C. K. et al. The Efficacy of Intranasal Fluticasone Propionate in the Relief of Ocular Symptoms Associated With Seasonal Allergic Rhinitis. Allergy and Asthma Proceedings. 24(5): 331-337, 2003. 8. Data on file, GlaxoSmithKline. (GSK: Result Summary for Study FNM30034. Http://Www.Gsk-Clinicalstudyregister.Com/. 5-12-2005). 9. FLONASE® Drug Facts Label. 10. Meltzer, E. O., Rickard, K. A., Westlund, R. E., and Cook, C. K. Onset of Therapeutic Effect of Fluticasone Propionate Aqueous Nasal Spray. Annals of Allergy, Asthma and Immunology. 86(3): 286-291, 2001. 11. Data on file, GlaxoSmithKline. GSK: Result Summary for Study FLN-444. Http://Www.Gsk-Clinicalstudyregister.Com/. 12-19-2005. 12. Data on file, GlaxoSmithKline. GSK: Result Summary for Study FLN-445. Http://Www.Gsk-Clinicalstudyregister.Com/. 12-14-2005. 13. Data on file, GlaxoSmithKline. GSK: Result Summary for Study R1810220. Http://Www.Gsk-Clinicalstudyregister.Com/. 6-29-2005. 14. Data on file, GlaxoSmithKline. GSK: Result Summary for Study R1810221. Http://Www.Gsk-Clinicalstudyregister.Com/. 6-29-2005.